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osting by EAbstract Purpose: To compare the safety and efﬁcacy of Pascal laser photocoagulation in com-
parison with the conventional laser photocoagulation in the treatment of diabetic retinopathy.
Patients and methods: A prospective randomized case series study was done on 120 procedures
done in 120 patients divided into two main groups, group A, patients undergoing focal or modiﬁed
grid macular laser and group B, patients undergoing panretinal photocoagulation (PRP). Each of
the two groups were subdivided into two subgroups randomly in the ﬁrst we used conventional laser
photocoagulation (groups A1 and B1) and in the other we used Pascal laser photocoagulation
(groups A2 and B2).
Results: Procedures in groups A1,2 and in groups B1,2 had successful outcomes. Signiﬁcantly
higher powers were required with the Pascal (groups A2 and B2) than with conventional laser
(groups A1 and B1) (p< 0.001) in eyes that underwent PRP and focal/modiﬁed grid macular treat-
ment with both systems. No adverse events were noted in all groups.
Conclusion: The Pascal photocoagulator is safe, rapid, effective, with rapid learning and had short
exposure time. Although the shorter pulse duration of the Pascal necessitates the use of a higher
power, it is not associated with adverse effects.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.551228104.
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Saud University.
lsevier1. Introduction
Laser photocoagulation remains the second-most common eye
procedure after cataract extraction, and yet little has changed
in laser design over the last 35 years until recently. There are
different colours, different laser sources and connecting cables,
but otherwise we were still tied to the same single spot delivery
system coupled to a slit lamp controlled by a joy stick.
Conventional photocoagulation using a single application of
laser energy per shot is usually delivered as a 100–200 ms dura-
tion burn. This gets difﬁcult for the patients and the treating
doctors and takes a long time especially in PRP (Roider
et al., 2000).
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ta Clara, CA, USA), which received United States Food and
Drug Administration (FDA) clearance in 2005 uses a micropro-
cessor-driven scanner that produces a variety of scalable pat-
terns, viewable on a computer screen and selected by the
physician. The laser allows the operator to apply multiple spots
almost simultaneously, with a single foot pedal depression, mul-
tiple laser burns in a rapid predetermined sequence in the form
of a pattern array produced by a scanner. To achieve this, pulse
durations are reduced by nearly a log unit to about 10–20 ms
compared with 100–200 ms with a traditional laser. This offers
several potential advantages over conventional single spot laser,
including increased uniformity and precision of spot placement
and reduced pain (Muqit et al., 2009).
But as the type of damage mechanism to retinal pigment
epithelium (RPE), other retinal layers and choroid depends
on the duration of the applied laser pulse. At continuous wave
(CW) to 10-ms exposure time, a pure thermal denaturation of
tissue has been shown to be the primary retinal damage mech-
anism (Vogel and Lauterborn, 1988). While from microsecond
to nanosecond exposure times, there is evidence that RPE
damage is induced by intracellular microbubble formation
around the strongly absorbent melanosomes inside the RPE
cell (Brinkmann et al., 2000). The microbubble formation leads
to a disintegration of the RPE cell structure and a disruption
of the cell membrane. At subnanosecond exposures, other non-
linear damage mechanisms appear, such as shock-waves and
laser-induced breakdown (Roegener et al., 2004).
Hence we did this prospective randomized case series
study to compare the safety and effectiveness of Pascal laser
photocoagulation in comparison with the conventional laser
photocoagulation in cases of diabetic retinopathy (DR).2. Patients and methods
A prospective randomized case series study was done after ap-
proval from medical and ethics committee. Informed written
consents were taken from all patients for the speciﬁc proce-
dure. Information was collected on age, sex, indication, pre-
and post-laser procedure best corrected visual acuities
(BCVA), need for subtenon’s anaesthetic as well as outcome
and complications of treatment and intra- and post-procedure
pain sensation.
Inclusion criteria were patients with type 2 DR with need
for laser either non-proliferative diabetic retinopathy (NPDR)
with clinically signiﬁcant macular oedema (CSME), focal or
diffuse maculopathy and proliferative diabetic retinopathy
(PDR).
Exclusion criteria were ischaemic maculopathy, previous la-
ser or intravitrial injection, vitrectomy or associated retinal
diseases as retinal vein occlusion.
Treatment parameters including use of a pattern or single
spot, type of pattern, power, burn duration and number of
burns per session were noted. The power, numbers of burns,
spot size and burn duration were recorded in an effort to com-
pare the settings needed with each system. Prior to starting
treatment, the operator chose whether or not to do Pascal
based on the random distribution by computer system after in-
formed consents from all patients.
One hundred and twenty procedures of 120 patients divided
into four groups: group A1, patients undergoing focal ormodiﬁed grid macular laser photocoagulation for NPDR using
conventional laser (The Novus Spectra which is a 532 nm
green-light Diode Pumped Solid State (DPSS) Photocoagula-
tor, Lumenis) with treatment durations: 10–3000 ms, spot size
from 50 lm up to 500 lm and power from 50 mW up to
2500 mW.
Group B1, patients undergoing pan laser photocoagulation
(PRP) for (PDR) using conventional (DPSS) laser photocoag-
ulation, group A2, patients undergoing focal or modiﬁed grid
macular laser photocoagulation for NPDR using Pascal laser
photocoagulation and group B2, patients undergoing PRP
for PDR using Pascal laser photocoagulation.
The Pascal (by OptiMedica, Silicon Valley, USA) is a
532 nm frequency-doubled (Nd:YAG) solid-state laser. It can
deliver numerous patterns including squares, arcs, full and
subset grids, the shapes and sizes of which are adjustable, in
addition to single spots. For PRP, the 3 · 3, 4 · 4 and 5 · 5 ar-
rays were most commonly used. Whether single spot or pattern
array near-simultaneously setting was used with a single
depression of the foot switch. All burns were placed one burn
width apart.
For Pascal laser, subset grids and single spots were used for
focal macular oedema. The full macular grid pattern was used
for patients with diffuse macular oedema who had good ﬁxa-
tion, but single spots were used for the rest. PRP group re-
ceived 20 ms, 200 lm spot size in air using a contact lens
with a spot-size magniﬁcation factor of 2· producing burns
of approximately 350–400 lm on the retina. Macular photoco-
agulation was performed using 10 ms exposures and a spot size
of 100 lm in air which produced a 6100 lm burn on the mac-
ula because a contact lens with a spot-size magniﬁcation factor
of 1· was utilised. Follow up was scheduled to be for 1 year
clinically by BCVA, slit lamp biomicroscopy, indirect ophthal-
moscopy, fundus photography and fundus ﬂuorescein angiog-
raphy (FFA).
Power needs to be varied in Pascal as with conventional
lasers until the desired burn intensity is achieved according
to variation in laser uptake due to contact lens curvature,
refraction, eye curvature and tissue characteristics such as pig-
mentation and extent of retinal oedema and exudation, though
efforts were made to avoid previous laser burns by adjusting
the location of the arrays as necessary or changing the array
pattern. Moderate intensity burns producing retinal blanching
were used for PRP while macular burns were lighter. Treat-
ment for groups A1 and A2 was deemed successful if the mac-
ula was dry and the oedema had resolved after 4 months,
Groups B1 and B2 was deemed successful if, neovascularisa-
tion had regressed, and no further treatment was planned.
Data were analysed using SPSS (Statistical Package for So-
cial Sciences V.17). Descriptive statistics were used to summa-
rise data and explore groups. Visual acuities (VA) were
converted from Snellen to log Mar to explore changes in vision
pre- to post-laser. p value of <0.05 was considered signiﬁcant
and highly signiﬁcant (p< 0.001).3. Results
In the study, 120 procedures of 120 patients were performed,
of whom 72 (60%) were male, and 48 (40%) were female with
a mean age of 48.9 years (SD 9.3, range 41–86). VA did not
differ signiﬁcantly pre- to post-procedure (p= 0.347) in any
Table 1 Different pre- and post-laser parameters in all groups.
Parameters Group A1 ME+ CL Group B1 PDR+ CL Group A2 ME+ PL Group B2 PDR+ PL
No. of procedures 30 30 30 30
Prelaser VA log MAR, mean (SD) 0.30 (0.24) 0.31 (0.23) 0.30 (0.24) 0.6 (0.61)
Snellen equivalent 6/12 6/12 6/12 6/24
Post-laser VA log MAR, mean (SD) 0.22 (0.24) 0.30 (0.27) 0.30 (0.24) 0.53 (0.61)
Snellen equivalent 6/9 6/12 6/12 6/18
Power (mW), mean (SD) 100 (20.5) 215 (51.3) 332 (105.5) 410 (115.2)
No. of burns, mean (SD) 85 (76.6) 700 (201.1) 145 (92.2) 1090 (410.4)
Average follow-up (weeks), mean (SD) 10.8 (4.3) 10.8 (5.6) 9.32 (3.2) 9.0 (4.5)
Successful outcome 27/30 20/30 28/30 28/30
ME, macular oedema; CL, conventional laser; PL, Pascal laser.
log MAR, logarithm of the minimal angle of resolution; VA, visual acuity.
Figure 1 (A) Modiﬁed grid by conventional laser. (B) PRP for PDR with combined conventional laser and Pascal photocoagulation for
comparison.
Figure 2 Combined PRP and modiﬁed grid by Pascal laser.
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in group A2, 30 (25%) in group B1 and 30 (25%) in group B2.
The average laser power, number of burns and mean follow-up
period for the whole of groups are listed in Table 1.
The results were compared in terms of efﬁcacy, power
requirement, procedure length, pain and adverse events. The
PASCAL burns were more precisely spaced and more uniform
than the conventional single-spot burns (Fig. 2), higher power
is required for the shorter time burns, and there was less sub-
jective patient discomfort noted. On a scale of 0–5, with 5
being the most painful, standard laser was rated 2.72 by the
patients and 0.61 for PASCAL.
Group A1 included 30 procedures with conventional laser,
of which 17 (56.7%) was modiﬁed grid laser for diffuse dia-
betic macular oedema and 13 (43.3%) were focal treatments
for focal diabetic macular oedema. Average power of
100 mW (SD 20.5, range 70–150), spot size 50–100 lm and
burn duration of 50–100 ms. The mean number of burns was
85 (SD 76.6, range 15–276) (Fig. 1).
For group A2 included 30 procedures with Pascal laser 20
(66.7%) modiﬁed grid laser for diffuse diabetic macular oede-
ma and 10 (33.3%) focal laser for focal macular oedema using
the Pascal pattern and two using single spots.
Average power used in group A2 was 332 mW (SD 105.5,
range 200–400), spot size 50–100 lm and burn duration of10 ms. The mean number of burns was 145 (SD 92.2, range
120–250) (Figs. 1 and 2).
Signiﬁcantly higher powers were used for Pascal (145 mW)
than conventional laser (100 mW) (p< 0.001) treatment.
Following Pascal treatment, in 28 of the 30 procedures, the
macula was dry, and no further laser was required. Two
patients had residual CSME, of which one underwent further
178 A.G. Salmanlaser, and one had intravitreal triamcinolone acetonide. Topi-
cal anaesthesia was sufﬁcient in all groups.
For group B1 (30 procedures) with PRP by conventional la-
ser for PDR the laser power needed using a 100 ms burn The
average power was 215 mW (SD 53.1, range 150–400), and the
mean number of burns was 700 (SD 201.1, range 300–1200).
For Pascal laser in group B2 (30 procedures) using a 20 ms
burn mean power was 410 mW (SD 115.2, range 250–760), and
the mean number of burns was 1090 (SD 410.4, range 440–
2050) (Fig. 2).
The difference in powers used with the conventional and
the Pascal lasers was highly signiﬁcant (p< 0.001).
In our study success rate was nearly same in conventional
A1 (27/30) and Pascal laser A2 (28/30) in cases of macular
oedema.
This success rate was signiﬁcantly higher (p< 0.05) with
Pascal laser PRP group B2 (28/30) than conventional laser
PRP group B1 (20/30) in PDR.
The Pascal was used for additional ﬁll-in PRP in 10 of the
30 procedures of group B1 which had conventional laser pho-
tocoagulation, but this had not adequately controlled the neo-
vascularisation. This group, therefore, allowed us to directly
compare the laser power needed using a 100 ms burn for the
conventional treatment with the laser power needed for the
same eye during the Pascal episode using a 20 ms burn. The
average power with the conventional photocoagulator for
these 10 procedures was 225 mW (SD 51.2, range 160–400),
and the mean number of burns was 725 (SD 221.2, range
300–1150). The Pascal parameters used for these 10 procedures
were as follows: mean power was 400 mW (SD 110.2, range
240–750), and the mean number of burns was 1110 (SD
420.2, range 450–2000).
The difference in powers used with the conventional and
the Pascal laser for these 10 patients was highly signiﬁcant
(p< 0.001), being 400 mW for Pascal compared with
225 mW for conventional laser.
Of these 10 procedures, 9 were successful with regression of
neovascularisation at their latest follow-up visit. One eye
needed further laser. Three patients had needed a subtenon’s
anaesthetic for their conventional laser session, but none of
them required it for their Pascal procedure.
Of the 30 PRP procedures done exclusively with the Pascal,
14 (46.7%) were performed in a single session, and the rest
were fractionated into two episodes. The mean number of
burns given during single-session PRP was 1410 (SD 562.5,
range 500–2000). None of the eyes with single-session PRP
developed any complications, and regression of neovasculari-
sation was noted in all, with no further treatment planned at
their last follow-up visit.
No complications related to laser treatment were noted in
any patient. No effects were observed on blood vessels if the
array inadvertently involved a retinal area traversed by blood
vessels. None of the patients experienced bleeding of either ret-
inal or choroidal origin. No effects were observed due to the
doctor being unable to avoid old laser burns in re-treatments.4. Discussion
The interaction of laser radiation with biological tissue is of
interest both for medical applications and for the establish-
ment of laser safety standards. Laser treatments of retinaldiseases are widely used in ophthalmology. During photocoag-
ulation, the aim is to optimise thermally induced therapeutic
effect but cause minimal retinal damage. Laser–tissue interac-
tion is inﬂuenced by wavelength, spot size, power and exposure
time. Retinal damage can be reduced by changing some of
these parameters. Pascal technology utilises an exposure time
of 10 ms for macular photocoagulation and 20 ms for PRP
(Jain et al., 2008). Our study revealed that this brief exposure
requires a higher power to achieve the desired therapeutic
lesion.
In group A, the mean power used was signiﬁcantly higher
with the Pascal system (145 mW) than with the conventional
system (100 mW) (p< 0.001). So higher power settings were
needed with the Pascal system as compared with conventional
photocoagulation.
Similarly 30 eyes with PRP in group B1 underwent photo-
coagulation with conventional laser and 10 needed additional
Pascal PRP. There was a highly statistically signiﬁcant differ-
ence in the mean power used between conventional laser
(225 mW) and Pascal laser (400 mW) (p< 0.001).
However, these higher power levels required with the Pascal
system did not result in any complications. This may be a
reﬂection of the reduced laser energy per burn reaching the
eye secondary to its shorter duration. Fluence is calculated
as (power · time/area), and provided that spot size remains
unchanged, with a burn duration of 20 ms the ﬂuence is less
than with a 100 ms burn when titrating to the same burn inten-
sity because of reduced diffusion of heat (Bailey et al., 1999).
In our study success rate was signiﬁcantly higher with Pas-
cal laser PRP than conventional laser PRP in PDR and Pascal
was successful in case of failed conventional laser (10 proce-
dures). This can be explained by the easier way to apply Pascal
laser to all retina in a shorter time and more comfortable for
the patient and the doctor while in conventional laser some
areas of the retina can be missed which increase failure rate.
Also previous study showed that regression of neovascularisa-
tion is associated with greater areas of retinal ablation at the
initial treatment session (Bailey et al., 1999). The cumulative
total number of burns (Cordeiro et al., 1997).
This success rate was nearly same in conventional and Pas-
cal laser in cases of macular oedema as it is easily accessible for
application of laser.
There has been some concern that very short exposures may
cause acoustic shock wave damage and haemorrhage. Some
early argon laser studies showed a narrow safety margin be-
tween retinal burn and retinal haemorrhage for pulse durations
less than 50 ms (Mainster et al., 1983; Obana et al., 1992). It
has been since then shown that the point of change from
thermomechanical cavitation-induced RPE damage to pure
thermal RPE denaturation occurs at a 50 ls exposure time, a
much shorter time than that employed by the Pascal system.
At pulse durations longer than 10 ms, pure thermal denatur-
ation of tissue is the primary retinal damage mechanism
(Schuele et al., 2005; Sliney and Marshall, 1992). It is this ther-
mal effect that produces therapeutically desirable retinal le-
sions (Mellerio, 1966). In histopathological study (Blumenkranz
et al., 2006) using pulse durations of 20 ms, the threshold for a
visible burn was 110–120 mW, while that for retinal haemorrhage
was 600 mW, suggesting an adequate safety margin. Another
recent study eyes has demonstrated that 20 ms pulse durations
represent an optimal compromise between reduced collateral
damage and sufﬁcient width of the therapeutic window
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Pascal laser as there were no intra or postoperative complications
for 1 year follow up.
At a 5-ls laser pulse duration, microbubble formation has
been shown to be the primary RPE damage mechanism. The
point of change from thermomechanical microbubble induced
RPE cell damage to pure thermal RPE denaturation is 50-ls
exposure time. At longer pulse durations, the primary damage
mechanism is purely thermal.
The array method of multiple burn application allows for a
larger area of retinal ablation in a shorter time. However,
although single-session PRP may be possible with the Pascal
system, its feasibility may be debatable due to concerns such
as macular oedema and exudative retinal and choroidal
detachments. In our patients, none who underwent single-
session PRP had any complications, but the numbers were
small to draw a conclusion. This was in agreement with Doft
and Blankenship, who found that these effects occurred more
in the ﬁrst few weeks after single-session PRP, but the effects
were transient, and no long-term difference between single
and multiple session treatment groups was found (Doft and
Blankenship, 1982).
In our patients, three patients who had previously under-
gone PRP using 100 ms burns required subtenon’s anaesthetic
for those procedures but were able to tolerate the Pascal pro-
cedure with only topical anaesthesia. A recent study has shown
that shortening the exposure time to 20 ms is signiﬁcantly less
painful but equally effective as conventional parameters
(ANSI, 2000).
5. Conclusions
From our study that we found that Pascal photocoagulator is
safe, rapid, effective, with rapid learning curve and had short
exposure time. Although the shorter pulse duration of the Pas-
cal necessitates the use of a higher power, it is not associated
with adverse effects.
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